電子薬局市場：薬剤の種類別、製品種類別、地域別（2026～2032年）

電子薬局市場の評価（2026～2032年）

スマートフォンとインターネット接続の普及により、オンライン医薬品ショッピングがより多くの人々にとって身近なものとなり、顧客は自宅に居ながらにして処方箋や市販薬を便利に入手できるようになりました。第二に、COVID-19の大流行によって拍車がかかった医療サービスのデジタル化の進行により、遠隔医療やオンライン診察が広く受け入れられるようになり、電子薬局サービスの需要は2024年に809億6,000万米ドルを超え、2032年には2,425億4,000万米ドルに達します。

個別化医療と服薬管理が重視されるようになったことで、電子薬局はカスタム型服薬リマインダーや健康モニタリングツールの提供など、サービス提供の革新を促し、競争が激化する市場で顧客満足度とロイヤルティを高めており、2026年から2032年までのCAGRは約14.70%で成長すると予想されます。

電子薬局市場の定義/概要

電子薬局（eファーマシー）とは、インターネットベースのプラットフォームを通じて医薬品や健康関連商品をオンラインで販売・流通させることです。この戦略により、顧客は処方薬や市販薬、健康サプリメント、パーソナルケア製品を自宅にいながら簡単に入手できます。電子薬局のアプリケーションには、オンライン処方箋補充、遠隔医療相談、健康モニタリングサービス、顧客への直接医薬品配達などが含まれます。電子薬局の将来は楽観的で、デジタルヘルス技術の進歩、インターネットアクセスの増加、効率的な医療ソリューションに対する需要の高まりが開発の原動力になると予想されます。医薬品のオンライン販売を可能にするルールが適応され、eヘルスの利点に対する消費者の認識が高まるにつれ、電子薬局ビジネスは急速に拡大し、よりパーソナライズされたサービスと顧客体験の向上を提供することになると思われます。

個別化医療の重視の高まりが、電子薬局市場を牽引するか？

個別化医療を重視する傾向が強まっていることから、電子薬局業界は大きく成長すると予想されます。技術的な向上により、電子薬局はデータ分析と人工知能を使用して、パーソナライズされた薬物療法と健康勧告を提供し、患者の関与と幸福を高めています。2023年9月、遠隔医療プラットフォームのTeladoc Healthは、独自の患者プロファイルに基づいて治療計画を強化することを目的とした新しい個別化医療プロジェクトの導入を発表しました。この動きは、個別化医療を目指す広範な業界動向を反映したものであり、電子薬局がカスタマイズされた健康ソリューションの需要に対応するのに有利な立場にあることを示唆しています。

例えば、米国食品医薬品局（FDA）は2023年7月、個別化医療をサポートするデジタルヘルス技術の使用を奨励するガイドラインを発表し、こうしたアプローチを既存の医療システムに組み込む必要性を強調しました。Verified Market Researchによると、電子薬局市場は、個別化医療サービスに対する需要の増加により、2024年から2032年の間にCAGR 14.70%で開拓されます。この技術革新と適切な法的枠組みの融合により、消費者が個別化された医療ソリューションを望むようになり、電子薬局分野は成長します。

医薬品販売に関する規制の高まりは、電子薬局市場の成長を妨げるか？

医薬品の販売に関する規制の高まりは、オンライン薬局にとって様々な法律を遵守することが大きな障害となるため、電子薬局ビジネスの拡大を妨げる可能性があります。多くの国の規制機関は、医薬品の安全性を保証するため、ライセンス認証、医薬品の品質モニタリング、患者のプライバシー保護など、厳しい基準を設けています。電子薬局はこれらの複雑な規則を管理しなければならず、運営コストや管理上の手間を増大させる可能性があります。特に小規模な企業は、これらの基準を満たすのに苦労する可能性があり、その結果、市場での競争やイノベーションが低下します。さらに、コンプライアンス違反のリスクは、電子薬局市場への新規参入企業の意欲をそぎ、全体的な成長見通しを制限する可能性があります。

厳格なルールは障害となる可能性がある一方で、顧客の信頼と安全性を高めることにも役立ち、長期的な市場成長にプラスの影響を与える可能性があります。規制の枠組みがより確立されれば、消費者はオンラインで医薬品を注文することに自信を持ち、評判の良い電子薬局サービスの需要が高まる可能性があります。このような環境では、規則遵守に成功した電子薬局は、評判と信頼性の向上を通じて差別化を図り、市場シェアを拡大する可能性があります。最後に、規制強化が電子薬局ビジネスに与える影響は、企業がユーザーのエンゲージメントとサービス品質を維持しながら、コンプライアンス・ニーズにどれだけ適応できるかによって決まります。

目次

第1章 世界の電子薬局市場：概要

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の電子薬局市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界の電子薬局市場：薬剤の種類別

• 概要
• 処方薬
• OTC（市販薬）

第6章 世界の電子薬局市場：製品種類別

• 概要
• スキンケア
• デンタル
• 風邪・インフルエンザ
• ビタミン
• その他

第7章 世界の電子薬局市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の電子薬局市場の競合情勢

• 概要
• 企業市場ランキング
• ベンダー情勢
• 主な発展戦略

第9章 企業プロファイル

• CVS Health Corporation
• DocMorris
• Express Scripts Holding Company
• Giant Eagle Inc.
• Optum Rx Inc.
• Rowlands Pharmacy
• The Kroger Co.
• Walgreen Co.
• Walmart Stores Inc

第10章 付録

• 関連分析

E Pharmacy Market Valuation - 2026-2032

The growing use of smartphones and internet connectivity has made online medication shopping more accessible to a wider audience, allowing customers to conveniently obtain prescriptions and over-the-counter drugs from the comfort of their own homes. Second, the ongoing digitization of healthcare services, spurred by the COVID-19 pandemic, has led to a wider acceptance of telehealth and online consultations, increasing demand for e-pharmacy services is surpassing USD 80.96 Billion in 2024 and reaching USD 242.54 Billion by 2032.

The growing emphasis on personalized healthcare and medication management has prompted e-pharmacies to innovate their service offerings, such as providing customized medication reminders and health monitoring tools, thereby increasing customer satisfaction and loyalty in an increasingly competitive market is expected to grow at a CAGR of about 14.70% from 2026 to 2032.

E Pharmacy Market: Definition/ Overview

E-pharmacy, or electronic pharmacy, is the online selling and distribution of pharmaceuticals and health-related items via internet-based platforms. This strategy enables customers to easily obtain prescription and over-the-counter pharmaceuticals, health supplements, and personal care products from the comfort of their own homes. E-pharmacy applications include online prescription refills, telemedicine consultations, health monitoring services, and direct pharmaceutical delivery to customers. The future of e-pharmacy seems optimistic, with development expected to be driven by advances in digital health technologies, increased internet access, and rising demand for efficient healthcare solutions. As rules adapt to allow online pharmaceutical sales and consumer awareness of e-health benefits grows, the e-pharmacy business is likely to increase rapidly, providing more personalized services and improved customer experiences.

Will Growing Emphasis on Personalized Healthcare Drive the E Pharmacy Market?

The growing emphasis on personalized healthcare is expected to fuel significant growth in the e-pharmacy industry, as customers seek tailored solutions to meet their individual health demands. With technological improvements, e-pharmacies are using data analytics and artificial intelligence to give personalized drug regimens and health recommendations, hence increasing patient engagement and happiness. In September 2023, Teladoc Health, a telehealth platform, announced the introduction of a new personalized medicine project aiming at enhancing treatment plans based on unique patient profiles. This move mirrors a broader industry trend toward personalized healthcare, implying that e-pharmacies are well-positioned to address the demand for customized health solutions.

For instance, in July 2023, the US Food and Drug Administration (FDA) issued guidelines encouraging the use of digital health technologies to support personalized medicine, highlighting the necessity of incorporating these approaches into existing healthcare systems. According to Verified Market Research, the e-pharmacy market will develop at a CAGR of 14.70% between 2024 and 2032, driven by increased demand for individualized healthcare services. This convergence of technical innovation and appropriate legal frameworks sets the e-pharmacy sector for growth as consumers desire personalized healthcare solutions.

Will Growing Regulations Regarding the Sale of Pharmaceuticals Hamper the Growth of the E Pharmacy Market?

Growing rules governing the selling of medications may stymie the expansion of the e-pharmacy business, as complying with various laws creates substantial obstacles for online pharmacies. Many countries' regulatory agencies have created severe criteria to assure medicine safety, such as licensing verification, drug quality monitoring, and patient privacy protection. E-pharmacies must manage these complex rules, which can raise operating costs and administrative hassles. Smaller companies, in particular, may struggle to fulfill these criteria, resulting in less competition and innovation in the market. Furthermore, the risk of non-compliance can dissuade new participants from entering the e-pharmacy market, restricting overall growth prospects.

While strict rules may provide obstacles, they also help to increase customer trust and safety, which could have a positive impact on long-term market growth. As regulatory frameworks become more established, consumers may gain confidence in ordering pharmaceuticals online, increasing demand for reputable e-pharmacy services. In this environment, e-pharmacies that successfully comply with rules may distinguish themselves through increased reputation and reliability, potentially acquiring a larger share of the market. Finally, the impact of increased restrictions on the e-pharmacy business will be determined by how well enterprises adapt to compliance needs while preserving user engagement and service quality.

Category-Wise Acumens

Will Rising Demand of Prescription Drugs Propel the E Pharmacy Market?

The increasing demand for prescription pharmaceuticals is expected to considerably boost the growth of the e-pharmacy industry, owing to factors such as increased chronic disease prevalence and the convenience of online ordering. As more patients require continuing medicine for ailments such as diabetes, hypertension, and mental health difficulties, e-pharmacies are well-positioned to address this growing demand by giving convenient access to important drugs. For instance, in September 2023, CVS Health declared a strategic focus on increasing its digital health services, highlighting the necessity of online prescriptions to improve patient access and drug management. This move highlights the synchronization of traditional pharmacy operations with consumers' changing requirements, demonstrating how established enterprises are shifting to capitalize on the e-pharmacy boom.

Furthermore, government initiatives promoting telehealth and digital healthcare solutions boost the e-pharmacy market's growth prospects. For instance, in April 2023, the United States Department of Health and Human Services (HHS) issued new guidelines to make telehealth services, such as online prescription refills, more accessible, particularly for mental health and substance use issues. These regulations aim to increase healthcare access for marginalized groups, which will have a direct influence on the e-pharmacy business by encouraging more patients to use online services for their prescriptions.

In contrast, the over-the-counter (OTC) pharmaceuticals segment is the fastest-growing category, driven by rising consumer awareness of health and wellness, as well as the convenience of ordering OTC meds online. The growing tendency of self-medication, particularly among younger consumers who prefer the convenience of online purchase, is driving this segment's expansion.

Will Rising Cases of Cold and Flu Drive the Growth of E Pharmacy Market?

The rising number of cold and flu cases is expected to generate significant growth in the e-pharmacy market, as more consumers seek easy and rapid access to over-the-counter pharmaceuticals and health items online. With a growing occurrence of respiratory illnesses, particularly during seasonal peaks, e-pharmacies are becoming a popular choice for those who want to treat their symptoms without having to visit a real pharmacy. In October 2023, Walgreens reported an increase in online sales of cold and flu treatments, reflecting consumer preferences toward seeking fast relief via digital platforms. The convenience of online buying, especially during illness when going out may be less tempting, allows e-pharmacies to grab a higher market share in this area.

For instance, in September 2023, the Centers for Disease Control and Prevention (CDC) initiated a campaign advocating vaccination and early treatment of flu symptoms, resulting in increased consumer demand for cold and flu treatments. The emphasis on accessibility and quick reaction to disease is well aligned with the ability of e-pharmacies to deliver health supplies directly to consumers' homes.

However, the skin care area is emerging as the fastest-growing category, owing to increased consumer interest in personal wellbeing, cosmetic products, and preventative healthcare. With the rise of social media and online beauty trends, more people are turning to e-pharmacies for skincare solutions, which include both medicinal and cosmetic items. This shift toward skin health and wellbeing reflects a substantial change in consumer behavior, setting the skin care category for strong growth in the e-pharmacy market.

Country/Region-wise

Will Widespread Internet Penetration in North America Drive the E Pharmacy Market?

The high internet access in North America is a major driver of the e-pharmacy sector. As of 2023, the Internet and Mobile Association of North America claimed that internet penetration in the region had reached 94.6%, with 392 million people routinely accessing online services. This high level of connection has made the environment ideal for the growth of e-pharmacy services. In February 2024, the Federal Communications Commission (FCC) revealed that 99% of Americans now have broadband internet connection, up from 93.5% in 2020. This enhanced accessibility has enabled more consumers to use online pharmacy services, particularly in rural areas where physical pharmacies are less accessible. The ease of obtaining prescriptions online, together with the opportunity to readily compare prices and access health information, has led to a surge in e-pharmacy adoption.

In March 2024, Amazon Pharmacy reported a 45% year-over-year rise in prescription orders, citing greater internet access and shifting consumer preferences. Similarly, CVS Health said in January 2024 that their digital pharmacy revenues had increased by 38% over the previous year, accounting for 25% of all prescription fills. On the regulatory front, the U.S. Food and Drug Administration (FDA) published new rules in September 2023 to make it easier for e-pharmacies to obtain licenses in several states, with the goal of facilitating the growth of online pharmacy services. A poll done by the National Association of Boards of Pharmacy in July 2023 indicated that 62% of North American customers have used an online pharmacy service at least once in the previous year.

Will Rising Demand for Convenient Access to Medications in Asia-Pacific Propel the E Pharmacy Market?

The Asia-Pacific region's increased desire for convenient drug access is expected to considerably accelerate the e-pharmacy industry, led by a growing population that is increasingly reliant on digital healthcare solutions. As more consumers in this region adopt online shopping and mobile applications, the e-pharmacy sector stands to benefit from the desire for convenient access to both prescription and over-the-counter drugs. For instance, in August 2023, India-based e-pharmacy PharmEasy reported a 60% growth in online medication orders, owing to a growing preference for home delivery. This trend demonstrates the region's shift toward digital healthcare solutions, as well as how convenience influences customer behavior.

Furthermore, government initiatives in the Asia-Pacific region are boosting the e-pharmacy market's growth prospects. In June 2023, the Chinese government issued new policies to promote the digitalization of healthcare services, including online pharmaceutical sales, with the goal of improving access for rural communities.

Competitive Landscaped

The competitive landscape of the e-pharmacy market is characterized by a dynamic interplay of established pharmacy chains, technology-driven startups, and online healthcare service providers. This market features a mix of local and global players, each vying for a share through innovative services, competitive pricing, and extensive product offerings. Companies are increasingly focusing on enhancing customer experience through user-friendly mobile apps and websites, along with personalized services such as telehealth consultations and medication reminders. Additionally, strategic partnerships and collaborations with healthcare providers and technology firms are becoming common as e-pharmacies seek to expand their reach and improve service delivery. Regulatory compliance and maintaining quality standards are also critical factors that influence competitive positioning in this rapidly evolving sector.

Some of the prominent players operating in the E pharmacy market include:

CVS Health Corporation

DocMorris

Express Scripts Holding Company

Giant Eagle,

Optum Rx,

Rowlands Pharmacy

The Kroger Co.

Walgreen Co.

Walmart Stores,

Latest Developments

In August 2023, Walgreens announced the development of its digital health services, with an emphasis on improving its e-pharmacy platform. In response to the increased demand for online healthcare solutions, the firm plans to improve the user experience with an upgraded mobile app that makes prescription refills and medication monitoring easier.

In September 2023, India-based e-pharmacy PharmEasy announced a strategic agreement with local healthcare providers to deliver individualized drug management services. This alliance seeks to improve patient participation and ensure timely delivery of critical medications, reflecting the growing emphasis on individualized healthcare solutions.

E Pharmacy Market, By Category

• Drug Type:
• Prescription Drugs
• Over the Counter Drugs
• Product Type:
• Skin Care
• Dental
• Cold
• Flu
• Vitamins
• Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL E Pharmacy MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL E Pharmacy MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL E Pharmacy MARKET, BY DRUG TYPE

• 5.1 Overview
• 5.2 Prescription Drugs
• 5.3 Over-the-counter (OTC) Drugs

6 GLOBAL E Pharmacy MARKET, BY PRODUCT TYPE

• 6.1 Overview
• 6.2 Skin Care
• 6.3 Dental
• 6.4 Cold and Flu
• 6.5 Vitamins
• 6.6 Others

7 GLOBAL E Pharmacy MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5. Rest of the World
  • 7.5.1. Latin America
  • 7.5.2. Middle East & Africa

8 GLOBAL E Pharmacy MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market ranking
• 8.3 Vendor Landscape
• 8.4 Key Development Strategies

9 COMPANY PROFILES

• 9.1 CVS Health Corporation
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 DocMorris
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Express Scripts Holding Company
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Giant Eagle Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Optum Rx Inc.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Rowlands Pharmacy
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 The Kroger Co.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Walgreen Co.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Walmart Stores Inc
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 APPENDIX

• 10.1 Related Research